11-76196604-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004626.3(WNT11):c.198G>A(p.Met66Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000126 in 1,613,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000070 ( 0 hom. )
Consequence
WNT11
NM_004626.3 missense
NM_004626.3 missense
Scores
5
8
6
Clinical Significance
Conservation
PhyloP100: 6.12
Genes affected
WNT11 (HGNC:12776): (Wnt family member 11) The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 97%, 85%, and 63% amino acid identity with mouse, chicken, and Xenopus Wnt11 protein, respectively. This gene may play roles in the development of skeleton, kidney and lung, and is considered to be a plausible candidate gene for High Bone Mass Syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.04260114).
BP6
Variant 11-76196604-C-T is Benign according to our data. Variant chr11-76196604-C-T is described in ClinVar as [Benign]. Clinvar id is 3047692.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 101 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WNT11 | NM_004626.3 | c.198G>A | p.Met66Ile | missense_variant | 2/5 | ENST00000322563.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WNT11 | ENST00000322563.8 | c.198G>A | p.Met66Ile | missense_variant | 2/5 | 1 | NM_004626.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000663 AC: 101AN: 152272Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
101
AN:
152272
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000247 AC: 62AN: 250566Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135630
GnomAD3 exomes
AF:
AC:
62
AN:
250566
Hom.:
AF XY:
AC XY:
16
AN XY:
135630
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000705 AC: 103AN: 1461282Hom.: 0 Cov.: 32 AF XY: 0.0000592 AC XY: 43AN XY: 726944
GnomAD4 exome
AF:
AC:
103
AN:
1461282
Hom.:
Cov.:
32
AF XY:
AC XY:
43
AN XY:
726944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000663 AC: 101AN: 152390Hom.: 0 Cov.: 34 AF XY: 0.000631 AC XY: 47AN XY: 74522
GnomAD4 genome
AF:
AC:
101
AN:
152390
Hom.:
Cov.:
34
AF XY:
AC XY:
47
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
13
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
34
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Bladder exstrophy-epispadias-cloacal extrophy complex Benign:1
Benign, criteria provided, single submitter | research | Obstetrics and Gynecology Department, Johns Hopkins School Of Medicine | - | - - |
WNT11-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 15, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Uncertain
Sift
Pathogenic
D;.
Sift4G
Uncertain
T;T
Polyphen
D;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0902);Loss of MoRF binding (P = 0.0902);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at